Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Longitudinal Study of Bone Mineral Density in Survivors of Solid Pediatric Cancers
A completed longitudinal clinical trial examining bone mineral density in survivors of solid pediatric cancers, focusing on osteoporosis.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers
This completed trial evaluated bone mineral density and osteoporosis risk in adult survivors of pediatric solid tumors who received chemothe…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Osteoporosis Prevention With Low Dose Alendronate [Phase 3]
A Phase 3 trial evaluating low-dose alendronate for osteoporosis prevention in individuals with osteopenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Calcium and Bone Mass in Young Females [Phase 2]
A Phase 2 clinical trial from Ohio State University assessing calcium's effect on bone mass in young females with osteoporosis has completed…
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Bone Estrogen Strength Training [Phase 2]
Phase 2 clinical trial update for Bone Estrogen Strength Training in osteoporosis has completed. The sponsor is the University of Arizona.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-05-15Clinical Trial Update: Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
This clinical trial update investigates treatment compliance, persistence with osteoporosis therapy, and attitudes toward future therapy amo…
-
EMA withdrawal · 2013-05-13EMA Withdrawn: Bondenza (previously Ibandronic Acid Roche) (ibandronic acid) — Roche Registration Ltd.
The EMA indicates that Bondenza (ibandronic acid) has been withdrawn from the market.
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: Effects of Unilateral WBV on Muscleactivity of Contralateral Hip Adductor [NA]
This completed clinical trial investigated how unilateral whole-body vibration affects muscle activity in the contralateral hip adductor, in…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Evaluation of Outcomes of DFine StabiliT Kyphoplasty in Vertebral Compression Fractures Due to Osteoporosis
A completed clinical trial evaluating the outcomes of the DFine StabiliT Kyphoplasty system for vertebral compression fractures due to osteo…
-
FDA approval · 2013-04-19FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for Actonel (risendronate sodium).
-
FDA approval · 2013-04-19FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
The FDA approved a supplemental NDA for Fosamax Plus D (alendronate sodium and cholecalciferol) from Organon LLC. The action approves a supp…
-
FDA approval · 2013-04-19FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Atelvia (risendronate sodium) submitted by Allergan, Inc.
-
FDA approval · 2013-04-19FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)
The FDA has approved a supplemental application for BINOSTO (alendronate sodium) from Radius Health, Inc. The approval updates the labeling …
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects [Phase 1]
A Phase 1 study in healthy volunteers evaluated whether a single 150 mg risedronate tablet is bioequivalent to two 75 mg tablets.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose [Phase 1]
Phase 1 pharmacokinetic study examining a single 14C-labeled dose of risedronate or alendronate followed by a weekly unlabeled dose in peopl…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women [Phase 3]
Pfizer completed a Phase 3 trial evaluating bazedoxifene acetate for osteoporosis in postmenopausal women; results have been posted.
-
FDA approval · 2013-03-29FDA Approved: ALENDRONATE — Supplemental Application (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for alendronate sodium tablets from Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
-
FDA approval · 2013-03-29FDA Approved: ZOLEDRONIC ACID — Original Application (Dr.Reddy's Laboratories Ltd)
FDA approved the original application for Zoledronic acid (generic) from Dr. Reddy's Laboratories Ltd. This approval confirms a generic vers…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Improving Care of Osteoporosis: Multi-Modal Intervention to Increase Testing and Treatment (ICOMMIITT) [NA]
A completed clinical trial update evaluating a multi-modal intervention to increase testing and treatment for osteoporosis.
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Bone Health in Type 1 Diabetes
A completed clinical trial evaluating bone health in people with type 1 diabetes and osteoporosis. The document does not specify results.
-
FDA approval · 2013-03-08FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ibandronate sodium submitted by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Acetaminophen and Impaired Musculoskeletal Adaptations to Exercise Training [NA]
Clinical trial update for NCT01083901 evaluating the effect of acetaminophen on impaired musculoskeletal adaptations to exercise training; r…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Post-menopausal Women Osteoporosis(Phase III) [Phase 3]
A Phase III trial for osteoporosis in postmenopausal women has completed, but no efficacy or safety results are provided in the update.
-
FDA approval · 2013-03-04FDA Approved: ZOLEDRONIC ACID — Original Application (Mylan Institutional LLC)
FDA approved an original application for a zoledronic acid generic product manufactured by Mylan Institutional LLC.
-
FDA approval · 2013-03-04FDA Approved: ZOLEDRONIC ACID — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's zoledronic acid under an original application, enabling a generic version of the drug.